Annual Report 2018


"Enduring Edge"


Consolidated Annual Report 2018



Biocon Annual Report 2018 captures Biocon’s journey of endurance across the arduous and long path of innovation-led biotechnology research, which has given the Company the edge in bringing to patients life-saving biopharmaceuticals for chronic therapies like Diabetes, Oncology and Immunology that are affordable and thus accessible.


BIOCON’S JOURNEY OF ENDURANCE: Download

FINANCIAL REPORT: Download

CHAIRPERSON'S REVIEW: Download

CEO Q&A: Download

CFO Q&A: Download

BOARD OF DIRECTORS Q&A: Download

TRASTUZUMAB JOURNEY: Download

INSULIN GLARGINE JOURNEY: Download

BIOLOGICS STORY: Download

SCIENTIFIC ADVISORY BOARD: Download

SUSTAINABILITY: Download